0000880984-22-000014.txt : 20221115
0000880984-22-000014.hdr.sgml : 20221115
20221115194031
ACCESSION NUMBER: 0000880984-22-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221111
FILED AS OF DATE: 20221115
DATE AS OF CHANGE: 20221115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Javitt Daniel C.
CENTRAL INDEX KEY: 0001864534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38302
FILM NUMBER: 221392643
MAIL ADDRESS:
STREET 1: 1201 NORTH MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001719406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822844431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 484-254-6134
MAIL ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp.
DATE OF NAME CHANGE: 20171012
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-11-11
0
0001719406
NRX Pharmaceuticals, Inc.
NRXP
0001864534
Javitt Daniel C.
1201 NORTH MARKET STREET
SUITE 111
WILMINGTON
DE
19801
0
0
1
0
common stock
2022-11-11
4
S
0
49200
1.0063
D
9823701
I
by Glytech LLC
Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
Held by Glytech LLC of which the Reporting Person is the sole owner.
Daniel Javitt
2022-11-15